Muraki Y - Search Results

1

Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides.

Yoshino N, Takeshita R, Kawamura H, Murakami K, Sasaki Y, Sugiyama I, Sadzuka Y, Kagabu M, Sugiyama T, Muraki Y, Sato S. Yoshino N, et al. Among authors: muraki y. Scand J Immunol. 2018 Aug;88(2):e12698. doi: 10.1111/sji.12698. Scand J Immunol. 2018. PMID: 29935085 Free article.

2

A systematic assessment of the relationship between synthetic surfactants and mucosal adjuvanticity.

Yoshino N, Kawamura H, Sugiyama I, Sasaki Y, Odagiri T, Sadzuka Y, Muraki Y. Yoshino N, et al. Among authors: muraki y. Eur J Pharm Biopharm. 2021 Aug;165:113-126. doi: 10.1016/j.ejpb.2021.05.010. Epub 2021 May 15. Eur J Pharm Biopharm. 2021. PMID: 34004335

3

Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice.

Yoshino N, Takeshita R, Kawamura H, Sasaki Y, Kagabu M, Sugiyama T, Muraki Y, Sato S. Yoshino N, et al. Among authors: muraki y. Immun Inflamm Dis. 2018 Mar;6(1):117-127. doi: 10.1002/iid3.204. Epub 2017 Nov 3. Immun Inflamm Dis. 2018. PMID: 29105371 Free PMC article.

4

Optimization of trypsins for influenza A/H1N1 virus replication in MDCK SI-6 cells, a novel MDCK cell line.

Iskandar VI, Sasaki Y, Yoshino N, Abubakar RZR, Sato S, Muraki Y. Iskandar VI, et al. Among authors: muraki y. J Virol Methods. 2018 Feb;252:94-99. doi: 10.1016/j.jviromet.2017.11.006. Epub 2017 Nov 17. J Virol Methods. 2018. PMID: 29155214

5

Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.

Sasaki Y, Yoshino N, Sato S, Muraki Y. Sasaki Y, et al. Among authors: muraki y. J Virol Methods. 2016 Sep;235:105-111. doi: 10.1016/j.jviromet.2016.04.013. Epub 2016 Apr 30. J Virol Methods. 2016. PMID: 27142111

6

A mouse monoclonal antibody against influenza C virus attenuates acetaminophen-induced liver injury in mice.

Sasaki Y, Yoshino N, Okuwa T, Odagiri T, Satoh T, Muraki Y. Sasaki Y, et al. Among authors: muraki y. Sci Rep. 2021 Jun 3;11(1):11816. doi: 10.1038/s41598-021-91251-x. Sci Rep. 2021. PMID: 34083649 Free PMC article.

7

Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy.

Chiba Y, Sato S, Itamochi H, Yoshino N, Fukagawa D, Kawamura H, Suga Y, Kojima-Chiba A, Muraki Y, Sugai T, Sugiyama T. Chiba Y, et al. Among authors: muraki y. Int J Gynecol Cancer. 2017 Oct;27(8):1666-1674. doi: 10.1097/IGC.0000000000001081. Int J Gynecol Cancer. 2017. PMID: 28786875

8

Cocirculation of Influenza C Viruses with Distinct Internal Genome Constellations in Iwate Prefecture, Japan, in 2016.

Takahashi M, Obara T, Matsuzaki Y, Maisawa SI, Sasaki Y, Yoshino N, Shirasawa A, Iwabuchi K, Takahashi T, Kajita H, Ono Y, Ryo A, Kimura H, Muraki Y. Takahashi M, et al. Among authors: muraki y. Jpn J Infect Dis. 2018 Sep 21;71(5):393-395. doi: 10.7883/yoken.JJID.2018.204. Epub 2018 Jul 31. Jpn J Infect Dis. 2018. PMID: 30068890 Free article. No abstract available.

9

Saffold virus type 3 (SAFV-3) persists in HeLa cells.

Himeda T, Hosomi T, Okuwa T, Muraki Y, Ohara Y. Himeda T, et al. Among authors: muraki y. PLoS One. 2013;8(1):e53194. doi: 10.1371/journal.pone.0053194. Epub 2013 Jan 4. PLoS One. 2013. PMID: 23308162 Free PMC article.

10

Isolation of human parechovirus type 3 from an infant with sudden death.

Hayashi Y, Odagiri T, Echizenya T, Dewa K, Muraki Y. Hayashi Y, et al. Among authors: muraki y. Pediatr Int. 2022 Jan;64(1):e15305. doi: 10.1111/ped.15305. Pediatr Int. 2022. PMID: 36257624 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters